{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:18:52Z","timestamp":1759335532331},"reference-count":24,"publisher":"Japanese Society of Internal Medicine","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2013]]},"DOI":"10.2169\/internalmedicine.52.0118","type":"journal-article","created":{"date-parts":[[2013,7,31]],"date-time":"2013-07-31T23:36:47Z","timestamp":1375313807000},"page":"1727-1730","source":"Crossref","is-referenced-by-count":16,"title":["Varicella-Zoster Virus-associated Fulminant Hepatitis Following Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma"],"prefix":"10.2169","volume":"52","author":[{"given":"Hirobumi","family":"Saitoh","sequence":"first","affiliation":[{"name":"Department of Hematology, Japanese Red Cross Akita Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Nanjo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Akita University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinari","family":"Kawabata","sequence":"additional","affiliation":[{"name":"Department of Hematology, Akita Kumiai General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Hirokawa","sequence":"additional","affiliation":[{"name":"Cancer Centre, Akita University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Sawada","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Koc Y, Miller KB, Schenkein DP, et al. Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome: Biology of blood and marrow transplantation. Journal of the American Society for Blood and Marrow Transplantation 6: 44-49, 2000."},{"key":"2","unstructured":"2. Kim DH, Messner H, Minden M, et al. Factors influencing varicella zoster virus infection after allogeneic peripheral blood stem cell transplantation: low-dose acyclovir prophylaxis and pre-transplant diagnosis of lymphoproliferative disorders. Transpl Infect Dis 10: 90-98, 2008."},{"key":"3","unstructured":"3. Teranishi H, Sakiyama M, Nagatoshi Y, et al. Acute lymphoblastic leukemia complicated with varicella zoster virus meningoencephalitis and visceral dissemination after related bone marrow transplantation. Jpn J Clin Hematol 52: 287-292, 2011."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Peritz DC, Duncan C, Kurek K, Perez-Atayde AR, Lehmann LE. Visceral varicella zoster virus (VZV) after allogeneic hematopoietic stem cell transplant (HSCT) in pediatric patients with chronic graft-versus-host disease (cGVHD). J Pediatr Hematol Oncol 30: 931-934, 2008.","DOI":"10.1097\/MPH.0b013e31817e4b14"},{"key":"5","unstructured":"5. Leena M, Ville V, Veli-Jukka A. Visceral varicella zoster virus infection after stem cell transplantation: a possible cause of severe abdominal pain. Scand J Gastroenterol 41: 242-244, 2006."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Takatoku M, Muroi K, Kawano-Yamamoto C, Nagai T, Komatsu N, Ozawa K. Involvement of the esophagus and stomach as a first manifestation of varicella zoster virus infection after allogeneic bone marrow transplantation. Intern Med 43: 861-864, 2004.","DOI":"10.2169\/internalmedicine.43.861"},{"key":"7","unstructured":"7. Aoyama Y, Yamamura R, Shima E, et al. Successful treatment with foscarnet for disseminated varicella-zoster infection after reduced intensity stem cell transplantation in a case of relapsed refractory central nervous system lymphoma. Jpn J Clin Hematol 44: 451-455, 2003."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ishizawa J, Fujita H, Iguchi M, Tachibana T, Taguchi J, Ishigatsubo Y. Quantification of circulating varicella-zoster virus DNA for follow-up in a case of visceral varicella-zoster infection ameliorated with intravenous acyclovir. Int J Hematol 85: 242-245, 2007.","DOI":"10.1532\/IJH97.06127"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kawano N, Gondo H, Kamimura T, et al. Chronic graft-versus-host disease following varicella-zoster virus infection in allogeneic stem cell transplant recipients. Int J Hematol 78: 370-373, 2003.","DOI":"10.1007\/BF02983564"},{"key":"10","unstructured":"10. Yagi T, Karasuno T, Hasegawa T, et al. Acute abdomen without cutaneous signs of varicella zoster virus infection as a late complication of allogeneic bone marrow transplantation: importance of empiric therapy with acyclovir. Bone Marrow Transplant 25: 1003-1005, 2000."},{"key":"11","unstructured":"11. Akiyama H, Inoue T, Okoshi Y, et al. Varicella-zoster virus infection after hematopoietic stem cell transplantation. Jpn J Clin Hematol 41: 20-24, 2000."},{"key":"12","unstructured":"12. Yamazaki E, Kamijoh A, Taguchi J, et al. Fatal acute visceral disseminated varicella-zoster virus infection in a patient with chronic graft-versus-host disease. Jpn J Clin Hematol 45: 1053-1057, 2004."},{"key":"13","unstructured":"13. Hamanishi T, Nishikawa H, Kobayashi M, et al. Acute abdomina pain as a presenting symptom of varicella-zoster virus infection in an allogeneic bone marrow transplant. Jpn J Clin Hematol 39: 53-58, 1998."},{"key":"14","unstructured":"14. David DS, Tegtmeier BR, O'Donnell MR, Paz IB, McCarty TM. Visceral varicella-zoster after bone marrow transplantation: report of a case series and review of the literature. Am J Gastroenterol 93: 810-813, 1998."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Morishita K, Kodo H, Asano S, Fujii H, Miwa S. Fulminant varicella hepatitis following bone marrow transplantation. JAMA 253: 511, 1985.","DOI":"10.1001\/jama.1985.03350280067014"},{"key":"16","unstructured":"16. Rogers SY, Irving W, Harris A, Russell NH. Visceral varicella zoster infection after bone marrow transplantation without skin involvement and the use of PCR for diagnosis. Bone Marrow Transplant 15: 805-807, 1995."},{"key":"17","unstructured":"17. Perez-Oteyza J, Pascual C, Garcia-Larana J, Odriozola J, Rocamora A, Navarro JL. Abdominal presentation of varicella zoster infection after bone marrow transplantation. Bone Marrow Transplant 9: 217, 1992."},{"key":"18","unstructured":"18. Steer CB, Szer J, Sasadeusz J, Matthews JP, Beresford JA, Grigg A. Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir. Bone Marrow Transplant 25: 657-664, 2000."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Boeckh M, Kim HW, Flowers ME, Meyers JD, Bowden RA. Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation--a randomized double-blind placebo-controlled study. Blood 107: 1800-1805, 2006.","DOI":"10.1182\/blood-2005-09-3624"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Thomson KJ, Hart DP, Banerjee L, Ward KN, Peggs KS, Mackinnon S. The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation. Bone Marrow Transplant 35: 1065-1069, 2005.","DOI":"10.1038\/sj.bmt.1704959"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Asano-Mori Y, Kanda Y, Oshima K, et al. Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation. Am J Hematol 83: 472-476, 2008.","DOI":"10.1002\/ajh.21152"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Oshima K, Takahashi T, Mori T, et al. One-year low-dose valacyclovir as prophylaxis for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation. A prospective study of the Japan Hematology and Oncology Clinical Study Group. Transplant infectious disease: an official journal of the Transplantation Society 12: 421-427, 2010.","DOI":"10.1111\/j.1399-3062.2010.00541.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Hata A, Asanuma H, Rinki M, et al. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N Engl J Med 347: 26-34, 2002.","DOI":"10.1056\/NEJMoa013441"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Okamoto A, Abe A, Okamoto M, et al. Severe hepatitis associated with varicella zoster virus infection in a patient with diffuse large B cell lymphoma treated with rituximab-CHOP chemotherapy. Int J Hematol 96: 516-520, 2012.","DOI":"10.1007\/s12185-012-1160-4"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/52\/15\/52_52.0118\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:46:23Z","timestamp":1621446383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/52\/15\/52_52.0118\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":24,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.52.0118","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}